By Alec Mattinson2022-09-20T08:04:00
Former GSK consumer arm Haleon has posted double-digit growth in its first financial results as a listed company, although it expects growth to slow in the second half
Already have an account? Sign in here
Already have an account? Sign in here
You’ve used up your article allowance